It seems like some of the benefits from psychedelics come from allowing people to process trauma, and negative feelings. They find much stronger benefits when p

It seems like some of the benefits from psychedelics come from allowing people to process trauma, and negative feelings. They find much stronger benefits when patients are guided through integrating the experience with therapy. I would say this can happen without hallucinations, e.g. PTSD patients find they are no longer afraid to process trauma on MDMA and can revisit painful experiences. However, there also seem to be cases, particularly with psilocybin, where the hallucinations themselves are obviously providing the patient a new story or framework to think about something troubling, e.g. the cancer patient who comes to terms with death in a new way, and has a story about the process. So I don’t think the answer is so cut and dry- it depends on the drug and the patient.